Phase 3 Trial Begins for Combination Influenza and COVID-19 Vaccine
mRNA-1083 is an investigational combination vaccine designed to prevent influenza and COVID-19.
Individuals With Inflammatory Disease Did Not Have Higher Risk of VTE Following COVID-19 Infection
The study results also indicate no significant difference of venous thromboembolism risk between individuals with immune-mediated inflammatory diseases and individuals without.
Research Seeks to Aid Management of Type 2 Diabetes Through Dietary Education
An upcoming large-scale clinical trial of the Glucose Everyday Matters program will evaluate its safety and efficacy in managing type 2 diabetes.
Researchers Find Increased Risk of Atrial Fibrillation After Menopause
Stressful life events and poor sleeping patterns are linked to the development of atrial fibrillation in older women.
mRNA-1273 Vaccine Associated With Lower Risk of Adverse Events, Likelihood of COVID-19 Diagnosis
Compared to the BNT162b2 vaccine, the mRNA-1273 vaccine was associated with a lower risk of adverse events, which investigators speculate was due to interrelated safety and efficacy.
Merck Announces Positive Results From Phase 3 Pneumococcal Vaccine Trials
If approved, the V116 vaccine would be the first pneumococcal conjugate vaccine specifically designed for adults.
Better Sleep Consolidation, Absence of Obstructive Sleep Apnea Are Associated With Better Cognition Over 5 Years of Follow-Up
Further research is necessary in order to investigate whether poor sleep can be a potential risk factor for dementia.
Immunoprophylaxis Guidance for RSV Not Aligned With Current Hospitalization Patterns, Study Finds
Investigators urge policymakers to establish flexible models that maximize coverage when respiratory syncytial virus activity is high and minimize unnecessary doses when viral activity is low.
Multivitamin Supplementation May Be Linked With Improved Nutrition in Older Men
Multivitamins were associated with increased cellular oxygen consumption and more optimal blood nutrition biomarkers.
Point-of-Care Testing Shows Promise in Future, Concerns About Sensitivity Accuracy
The CDC has recommended a follow-up nucleic acid amplification test to be used for patients clinically suspected to have influenza, despite a negative POC test.
2 Clarke Drive Cranbury, NJ 08512